Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Hydrogel Urothelial Cancer Therapies
10
Mins
June 2025
Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…
Read more
10
Mins
4 May 2021
Reimagining Treatment of HR+, HER2- Early Breast Cancer
Dr Prat explained that there are three main variables that should be considered when determining the risk of recurrence for…
11
Mins
23 Mar 2021
Addressing the Unmet Need in Treatment of Nonmelanoma Skin Cancers: Interviews with Two Key Opinion Leaders
Nonmelanoma skin cancers (NMSC) are a diverse group of cutaneous malignancies and are the most common forms of human neoplasia worldwide…
3
Mins
19 Feb 2021
Final Results from the ClarIDHy Phase III Study of Ivosidenib Versus Placebo in Patients with Previously Treated Cholangiocarcinoma and an Isocitrate Dehydrogenase 1 (IDH1) Mutation
Cholangiocarcinoma (CCA) is a rare cancer for which there are limited effective therapies.1,2 Mutations in the isocitrate dehydrogenase 1 gene (IDH1)…
5
Mins
8 Feb 2021
Streptococcus suis and an Incidentally Diagnosed Metastatic Colon Cancer
Streptococcus suis is a zoonotic gram-positive bacterium that is usually acquired through direct contact with swine or pork…
10
Mins
12 Jan 2021
Expanding Possibilities in EGFR-Mutated Advanced NSCLC: Interviews with Four Key Opinion Leaders
Worldwide, there were approximately 2.10 million patients diagnosed with, and 1.77 million deaths caused by, lung cancer in 2018. Approximately…
6
Mins
16 Dec 2020
3rd Breast Cancer Virtual Masterclass Symposium: MONARCH 2, a Phase III Study of Abemaciclib or Placebo in Combination with Fulvestrant
More than 70% of patients diagnosed with metastatic breast cancer present with oestrogen-HR+ disease and are therefore candidates for endocrine…
8
Mins
5 Nov 2020
Next-Generation Sequencing Standard of Care for Molecular Profiling
Given that COVID-19 has posed unique challenges in cancer care, a number of speakers addressed, with evidence, the impact of COVID-19…
11
Mins
5 Nov 2020
Oncogenic Drivers in Advanced NSCLC: Navigating an Evolving Landscape to Optimise Patient Outcomes
The oncology community has been experiencing an unprecedented moment in lung cancer diagnosis and treatment; however, despite significant…
Loading posts...
« Previous
1
…
10
11
12
13
14
…
29
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View